Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.
Observation Gait Assessments in subjects with neurological disorders: A Systematic Review.
Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures.
Opexa Therapeutics reports third quarter 2013 financial results and provides corporate update
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Multiple sclerosis: new measures to monitor the disease.
Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
Teriflunomide and its mechanism of action in multiple sclerosis.
The right information can transform lives.
Falls in people with MS-an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis.
Response to comment on "dimethyl fumarate (tecfidera): a new oral agent for multiple sclerosis".
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells.
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Pages
« first
‹ previous
…
420
421
422
423
424
425
426
427
428
…
next ›
last »